TrialCancer medicine2021

Mismatch repair protein and MLH1 methylation status as predictors of response to adjuvant therapy in endometrial cancer.

Mikko Loukovaara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.